Regencell Bioscience Holdings (RGC) Assets Average (2025)

Regencell Bioscience Holdings' (RGC) quarterly Assets Average came in at $7.3 million in Q4 2025.

Regencell Bioscience Holdings (RGC) Assets Average (2025) Analysis & Trends

Regencell Bioscience Holdings (RGC) has 1 years of Assets Average data on file, last reported at $7.3 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Assets Avg. (Qtr)
1	Haleon	43.89 Bn	42.93 Bn	-	43.72 Bn
2	Teva Pharmaceutical Industries	43.01 Bn	39.35 Bn	2.15 Bn	39.95 Bn
3	Zoetis	31.52 Bn	29.84 Bn	1.05 Bn	15.12 Bn
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn	98.59 Bn
5	United Therapeutics	22.17 Bn	19.51 Bn	683.80 Mn	6.97 Bn
6	Viatris	18.73 Bn	17.85 Bn	1.46 Bn	35.94 Bn
7	Neurocrine Biosciences	15.51 Bn	15.12 Bn	935.80 Mn	5.13 Bn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	13.39 Bn
9	Dr Reddys Laboratories	10.12 Bn	9.96 Bn	-	5.97 Bn
10	Regencell Bioscience Holdings	2.72 Bn	2.72 Bn	-	7.26 Mn

Download Data

Date	Value
Dec 31, 2025	7.26 Mn